
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7555330
[patent_doc_number] => 08067231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Clostridial toxin activity assays'
[patent_app_type] => utility
[patent_app_number] => 11/908451
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 95577
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908451
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908451 | Clostridial toxin activity assays | Apr 3, 2006 | Issued |
Array
(
[id] => 5062612
[patent_doc_number] => 20070224251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Hemostatic material'
[patent_app_type] => utility
[patent_app_number] => 11/385750
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6884
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385750 | Hemostatic material | Mar 21, 2006 | Abandoned |
Array
(
[id] => 256216
[patent_doc_number] => 07575889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Compound combinations for inhibiting cell division and methods for their identification and use'
[patent_app_type] => utility
[patent_app_number] => 11/376259
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26798
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/575/07575889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376259 | Compound combinations for inhibiting cell division and methods for their identification and use | Mar 13, 2006 | Issued |
Array
(
[id] => 7800670
[patent_doc_number] => 08128940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems'
[patent_app_type] => utility
[patent_app_number] => 11/908349
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 198739
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/128/08128940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908349 | Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems | Mar 13, 2006 | Issued |
Array
(
[id] => 5786414
[patent_doc_number] => 20060205648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Liquid, aqueous pharmaceutical compositions of factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/353335
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16375
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205648.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353335
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353335 | Liquid, aqueous pharmaceutical compositions of factor VII polypeptides | Feb 13, 2006 | Issued |
Array
(
[id] => 5278593
[patent_doc_number] => 20090130725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Gene Sms 14'
[patent_app_type] => utility
[patent_app_number] => 11/883639
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17511
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883639 | Gene Sms 14 | Feb 9, 2006 | Abandoned |
Array
(
[id] => 5649671
[patent_doc_number] => 20060135406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion'
[patent_app_type] => utility
[patent_app_number] => 11/351001
[patent_app_country] => US
[patent_app_date] => 2006-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15914
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11351001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/351001 | Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion | Feb 8, 2006 | Abandoned |
Array
(
[id] => 4629156
[patent_doc_number] => 08008039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Polydiacetylene-containing solid colorimetric and /or fluorescent detector, method for its preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/795499
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5667
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795499
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795499 | Polydiacetylene-containing solid colorimetric and /or fluorescent detector, method for its preparation and uses thereof | Jan 18, 2006 | Issued |
Array
(
[id] => 5682982
[patent_doc_number] => 20060199252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Genes encoding the synthetic pathway for the production of disorazole'
[patent_app_type] => utility
[patent_app_number] => 11/330623
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 3217
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330623 | Genes encoding the synthetic pathway for the production of disorazole | Jan 11, 2006 | Abandoned |
Array
(
[id] => 5889802
[patent_doc_number] => 20060276392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Treatments employing neuronal exocytosis-inhibiting peptides'
[patent_app_type] => utility
[patent_app_number] => 11/327952
[patent_app_country] => US
[patent_app_date] => 2006-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5816
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327952 | Treatments employing neuronal exocytosis-inhibiting peptides | Jan 8, 2006 | Issued |
Array
(
[id] => 23316
[patent_doc_number] => 07794968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/328472
[patent_app_country] => US
[patent_app_date] => 2006-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8278
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/794/07794968.pdf
[firstpage_image] =>[orig_patent_app_number] => 11328472
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/328472 | Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof | Jan 8, 2006 | Issued |
Array
(
[id] => 5598096
[patent_doc_number] => 20060162014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules'
[patent_app_type] => utility
[patent_app_number] => 11/327762
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 34341
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20060162014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327762 | Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules | Jan 5, 2006 | Abandoned |
Array
(
[id] => 5865542
[patent_doc_number] => 20060099672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Activatable recombinant neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 11/326265
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15748
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099672.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326265 | Activatable recombinant neurotoxins | Jan 4, 2006 | Issued |
Array
(
[id] => 162881
[patent_doc_number] => 07671178
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-03-02
[patent_title] => 'Solubilization and reconstitution of silk using ionic liquids'
[patent_app_type] => utility
[patent_app_number] => 11/326678
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4337
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671178.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326678 | Solubilization and reconstitution of silk using ionic liquids | Dec 28, 2005 | Issued |
Array
(
[id] => 5678416
[patent_doc_number] => 20060183772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Anti-cancer compounds'
[patent_app_type] => utility
[patent_app_number] => 11/304269
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7260
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304269
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304269 | Anti-cancer compounds | Dec 13, 2005 | Issued |
Array
(
[id] => 5690134
[patent_doc_number] => 20060288449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Process for purifying target compounds from plant sources using ceramic filtration'
[patent_app_type] => utility
[patent_app_number] => 11/301469
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8519
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20060288449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301469
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301469 | Process for purifying target compounds from plant sources using ceramic filtration | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5678528
[patent_doc_number] => 20060183884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Compounds and methods for modulating cell adhesion'
[patent_app_type] => utility
[patent_app_number] => 11/299289
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 54774
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11299289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299289 | Compounds and methods for modulating cell adhesion | Dec 8, 2005 | Abandoned |
Array
(
[id] => 517240
[patent_doc_number] => 07189541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Botulinum toxin production method'
[patent_app_type] => utility
[patent_app_number] => 11/296015
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10183
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296015
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296015 | Botulinum toxin production method | Dec 6, 2005 | Issued |
Array
(
[id] => 582413
[patent_doc_number] => 07445914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => 'Animal product free media and processes for obtaining a botulinum toxin'
[patent_app_type] => utility
[patent_app_number] => 11/296001
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10179
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/445/07445914.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296001 | Animal product free media and processes for obtaining a botulinum toxin | Dec 6, 2005 | Issued |
Array
(
[id] => 177537
[patent_doc_number] => 07655244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions'
[patent_app_type] => utility
[patent_app_number] => 11/296079
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5388
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296079 | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions | Dec 6, 2005 | Issued |